当前位置:首页 >财报库 > 报告详情

三井物产株式会社三井物产株式会社波士顿科学Boston Scientific Corporation(BSX)2026年第一季度财务和运营亮点报告「NYSE」(英文版)(27页).pdf

上传人: Kell****reet 编号:1226762 2026-05-06 27页 682.50KB

下载:

1、Q1 2026 Financial&Operational Highlights|April22,2026 1Q1 2026 HighlightsApril22,2026Q1 2026 Financial&Operational Highlights|April22,2026 2Forward-Looking Statements and Use of DocumentForward-looking statements:This presentation contains forward-looking statements within the meaning of Section 27A

2、 of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.Forward-looking statements may be identified by words like anticipate,expect,project,believe,plan,estimate,may,intend and similar words.These forward-looking statements are based on our beliefs,assumptions and esti

3、mates using information available to us at the time and are not intended to be guarantees of future events or performance.These forward-looking statements include,among other things,statements regarding our expected net sales;reported,operational and organic revenue growth rates;adjusted EPS for the

4、 second quarter and full year 2026;free cash flow(FCF);adjusted expenses;tax rates;our financial performance;acquisitions;clinical trials;our business plans and product performance;and new and anticipated product approvals and launches.If our underlying assumptions turn out to be incorrect,or if cer

5、tain risks or uncertainties materialize,actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.These factors,in some cases,have affected and in the future(together with other factors)could affect our ability to implement our

6、business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this presentation.As a result,readers are cautioned not to place undue reliance on any of our forward-looking statements.Factors that may cause such differences can be found in

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **Q1 2026业绩**:净销售额52.03亿美元,同比增长11.6%(报告)/9.4%(运营/有机);调整后EPS为0.80美元,同比增长9.4%。 2. **业务亮点**: - 心血管业务净销售额35.03亿美元(+13.5%),其中电生理业务增长23.9%(+21.7%运营),WATCHMAN增长19.2%。 - 医疗外科业务净销售额17.01亿美元(+7.8%),内窥镜业务增长9.4%(+6.8%运营)。 3. **2026年指引**:全年净销售额增长7.0%-8.5%(报告)/6.5%-8.0%(有机),调整后EPS为3.34-3.41美元。 4. **关键进展**:公布WATCHMAN FLX和EKOS系统临床试验积极结果,完成收购Valencia Technologies。
**业绩增长动力?** **创新产品进展?** **未来市场预期?**
客服
商务合作
小程序
服务号
折叠